Sialoglycoconjugates in primary and recurrent mixed tumors of lacrimal glands

Koichi Hayakawa, Makoto Ishikawa, Tohru Abe, Ryuko Nakayama, Kunihiko Yamaki, Shozo Sakuragi

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

We examined the activity of Griffonia simplicifolia II agglutinin (GS2) before and after neuraminidase treatment in 2 cases of primary benign mixed tumor (BMT) and a case of recurrent mixed tumor (MT). Histologically, each type of MT is comprised of epithelial and mesenchymal components. GS2, which showed no binding to either structural component in the primary BMT, was specifically bound to the mesenchymal component in the recurrent MT. After neuraminidase treatment, there was a marked increase in GM-binding levels in the epithelial component of the primary BMT and in both components of the recurrent MT. These results might reveal a prominent sialylation in the recurrent MT.

Original languageEnglish
Pages (from-to)374-379
Number of pages6
JournalOphthalmic Research
Volume30
Issue number6
DOIs
Publication statusPublished - 1998 Nov
Externally publishedYes

Keywords

  • Benign mixed tumor
  • Griffonia simplicifolia II agglutinin
  • Lacrimal gland
  • Lectin cytochemistry
  • Neuraminidase treatment
  • Sialic acid

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'Sialoglycoconjugates in primary and recurrent mixed tumors of lacrimal glands'. Together they form a unique fingerprint.

Cite this